Upstream Bio (UPB) Non Operating Income (2023 - 2026)

Upstream Bio's Non Operating Income history runs 4 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• On a quarterly basis, Non Operating Income changed N/A year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was -$1.7 million, a 116.0% decrease from a year earlier, with the FY2025 full-year figure at -$15000.0, down 100.1% from the prior year.
• Non Operating Income grew to $3.0 million in Q1 2026 per UPB's latest filing, from -$13.2 million in the prior quarter.
• Across five years, Non Operating Income topped out at $19.7 million in Q4 2023 and bottomed at -$13.2 million in Q4 2025.
• The 4-year median for Non Operating Income is $4.1 million (2024), against an average of $3.9 million.
• Biggest YoY gain for Non Operating Income was 53.07% in 2025; the steepest drop was 360.54% in 2025.
• Year by year, Non Operating Income stood at $19.7 million in 2023, then slumped by 74.21% to $5.1 million in 2024, then plunged by 360.54% to -$13.2 million in 2025, then jumped by 122.87% to $3.0 million in 2026.
• Per Business Quant, the three latest UPB Non Operating Income figures stand at $3.0 million (Q1 2026), -$13.2 million (Q4 2025), and $4.1 million (Q3 2025).